- Home
- Products
- Customized FluoroAb™
- CD19
- Taplitumomab paptox-Cy3
Taplitumomab paptox-Cy3 (CAT#: ADC-FL-374)
This product is comprised of an anti-CD19 monoclonal antibody (Taplitumomab paptox) labeled with Cy3. Cy3 is a orange-fluorescent dye and it's excitation/emission is 554/568 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD19
- Alternative Names
- CD19; CD19 molecule; CD19 antigen; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4; B4; CVID3; MGC12802;
- Overview
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
- Overview
- Mouse Anti-CD19 IgG1-kappa antibody, Taplitumomab paptox
- Generic name
- Taplitumomab paptox
- Species Reactivity
- Human
- Name
- Cy3
- Color
- Orange
- Excitation⁄Emission (nm)
- 554/568
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- anti-CD70 antibody-iFluor 555 (CAT#: ADC-FL-888)
- Anti-CD70 MAb (Clone 9)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5147)
- anti-CD70 antibody-PBlue (CAT#: ADC-FL-900)
- Anti-HIV-1 MAb (Clone 4)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS3135)
- Anti-ERBB2 MAb (Clone 29)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8253)
- Ruplizumab-Cy5 (CAT#: ADC-FL-789)
- Anti-EpCAM MAb (Clone 7)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2080)
- Anti-ITGAE MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4129)
- Anti-FZD1 MAb (Clone 2)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2802)
- Anti-F3 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS246)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-374. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-776 | Anti-CD19 (Blinatumomab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2518 | Anti-CD19 (Denintuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-775 | Anti-CD19 (Taplitumomab paptox)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-322 | Anti-CD19-Mc-MMAF ADC-1 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-2517 | Anti-CD19 (Denintuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.